Blake is an engineer, scientist, and entrepreneur who has been working at GV since 2010. As an investor, Blake partners with founders on life-science and digital companies — from drug development and healthcare delivery to financial services and information security.
Blake’s life science investments include Denali (Nasdaq: DNLI), Armo (Acquired by Lilly), Forty Seven (Nasdaq: FTSV), Magenta (Nasdaq: MGTA) and Arcus (Nasdaq: RCUS). Blake’s digital investments include being the first investor in Robinhood and Gusto.
Prior to GV, Blake helped start two companies, led research projects on biomedical engineering and stem cell biology at Stanford, and was an angel investor.
Blake received a Ph.D. and master’s in bioengineering from Stanford University and holds Bachelor of Science degrees in biomedical engineering and economics from Duke University.